EAN 2023 | Therapeutic strategies targeting smoldering neuroinflammation in MS

Celia Oreja-Guevara, MD, PhD, University Hospital San Carlos, Madrid, Spain, explores potential therapeutic strategies or interventions targeting smoldering neuroinflammation in multiple sclerosis (MS). The microglia, part of the innate immune system, is the main player in smoldering inflammation. The use of BTK inhibitors to target the microglia and potentially reduce chronic inflammation is currently under investigation in clinical trials. This interview took place at the European Academy of Neurology (EAN) 2023 Congress in Budapest, Hungary.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.